Skip to main content

Avalon Pharma

أفالون فارما
4016 Main Market Shariah Compliant Buy
67.20 SAR
+1.20 (+1.82%)
Market Cap 2.35B SAR
Volume 235.66K shares
P/E Ratio 27.80
Dividend Yield 2.36%
52-Week Range Pharma, Biotech & Life Sciences
52.53
69.47
Last Updated: November 17, 2026 Confidence: 62%

Technical Analysis & Signals

Buy
Confidence 62%

Avalon Pharma closed at SAR 67.2, up 1.82%. RSI at 65.0 in neutral zone. Current signal: Buy.

Support 55.60 SAR
Resistance 68.40 SAR
Short-term (1-2 weeks) 69.22 SAR
Medium-term (1-3 months) 72.58 SAR
Risk Score
5/10 Medium
Technical Analysis

Avalon Pharma closed at SAR 67.2, above the 50-day SMA (63.18 SAR). RSI at 65.0 (neutral). MACD shows bullish momentum with histogram at 0.6837. Bollinger range: 56.61 – 67.14 SAR.

Support & Resistance Levels

Key support at SAR 55.6. Resistance at SAR 68.4. A break below support could push the stock toward SAR 53.93, while a breakout above resistance opens the path to SAR 70.45.

Volume Analysis

Session volume 235,658 shares is above the 30-day average (78,394 shares). Higher volume with price movement supports the current trend.

Fundamental Factors

P/E ratio at 27.8x. Dividend yield around 2.0%. Market cap SAR 2,352,000,000.0.

Risk Factors

Technical indicators sit in neutral territory (RSI 65, debt-to-equity 0.4114).

Recommendation

Based on current technical and fundamental data for Avalon Pharma. Monitor support at SAR 55.6 and resistance at SAR 68.4 for entry and exit points.

Analyzed: November 17, 2026, 6:05 PM Rule-based analysis

Financial Fundamentals

Market Cap 2.35B
P/E Ratio 27.80
P/B Ratio 5.40
EPS 2.42
Dividend Yield 2.36%
Dividend/Share 1.55
ROE 28.70%
Debt/Equity 0.41
Free Float 46.98%
Shares Outstanding 35.00M

Price Data

52-Week High 69.47
52-Week Low 52.53
3-Month High 68.40
3-Month Low 55.60
Open 65.00
Day's High 68.40
Day's Low 65.00
Previous Close 66.00

Price Chart - Avalon Pharma

4016

Technical Analysis

Current Price: 67.20 SAR
Overall Technical Signal Bullish Signal
7 Bullish 1 Neutral 1 Bearish

Moving Averages

SMA 20 61.88 SAR
Bullish
SMA 50 63.18 SAR
Bullish
SMA 200 60.54 SAR
Bullish
EMA 12 63.80 SAR
Bullish
EMA 26 62.91 SAR
Bullish
Current Price 67.20 SAR — Price above average = Bullish

Momentum Indicators

RSI 14
65.00 Neutral
Oversold (<30) Neutral Overbought (>70)
MACD Bullish
MACD 0.888
Signal 0.205
Histogram +0.684

Bollinger Bands

Above Upper Band
Upper Band 67.14 SAR
Middle Band 61.88 SAR
Lower Band 56.61 SAR
Price position within band
Lower Band Upper Band
Average True Range (ATR) 2.05 SAR

Trend Strength (ADX)

Weak Trend
19.7
Weak (<20) Moderate Strong (>40)
+DI (Bullish) 31.80
-DI (Bearish) 17.20
Dominant Trend: Bullish
On-Balance Volume (OBV) 3.37M shares

Financial Summary

Avalon Pharma

Valuation

Market Cap
2.35B
P/E Ratio
27.80
P/B Ratio
5.40
EPS (Earnings/Share)
2.42

Profitability

Revenue
528.49M
Net Income
115.66M
Return on Equity (ROE)
+28.70%
Shares Outstanding
35.00M

Balance Sheet

Total Assets
599.53M
Total Debt
178.82M
Debt/Equity
0.41
Free Float %
+47.0%

Dividends & Margins

Dividend Yield
+2.36%
Dividend/Share
1.55
Book Value
12.44

Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.

Historical Financial Data

3 years
Year RevenueNet IncomeTotal AssetsTotal DebtEPS
2025
460.48M +16.9%
97.01M +21.5%
599.53M +13.8%
63.84M +0.9%
2.77 +21.5%
2024
394.00M +16.4%
79.85M +21.3%
526.78M +16.4%
63.26M +2.0%
2.28 +21.3%
2023
338.44M
65.83M
452.74M
62.00M
1.88

Historical data sourced from Yahoo Finance and may differ from official audited financial reports.

Price Forecast

Buy
Buy
Confidence
62%
Price Range
Medium Target 72.58 +8.01%
Short Target 69.22 +3.01%
Resistance 68.40 +1.79%
Current Price 67.20
Support 55.60 -17.26%
Short-term Target 1-3 months
69.22 +3.01%
Medium-term Target 3-6 months
72.58 +8.01%
Upside +8.0%
Downside -17.3%
Risk/Reward Ratio Poor
0.46 : 1

These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.

News & Events

No news currently available for Avalon Pharma

Sector Comparison

Pharma, Biotech & Life Sciences

Dividend History

Avalon Pharma
Annual Total per Share
2026
1.55
2.3%
2025
1.34
2.0%
2024
0.43
0.6%
Amount per share Yield %
Recent Payments
September 2026 0.80
March 2026 0.75
September 2025 0.63
May 2025 0.71
September 2024 0.43

Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.

Ownership Structure

Locked Ownership53.02%
Free Float46.98%

Data source: Yahoo FinanceLast updated: 2026-11-17

Risk Assessment

Medium
Low 2
Medium 3
High 0

Risk Factors

!
Moderate Volatility Medium

Average True Range 3.1% of stock price

✓
Good Liquidity Low

Trading volume near or above average

!
Fair Valuation Medium

P/E ratio 27.8

✓
Low Debt Low

Debt-to-equity ratio 0.41

!
Weak Trend Medium

ADX indicator at 20 — no clear direction

Medium

Moderate risk factors with some sector pressures

Confidence Level 62%
Analysis Signal Buy

This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.

FAQ

6 question
1 What is Avalon Pharma stock price today?

Avalon Pharma (4016) stock price today is 67.20 SAR, gaining by +1.82% compared to the previous session close. The 52-week price range is between 52.53 SAR and 69.47 SAR.

2 What is Avalon Pharma stock valuation?

The automated analysis signal for Avalon Pharma is "Buy" with 62% confidence. The P/E ratio is 27.8. The P/B ratio is 5.40.

3 Is Avalon Pharma Shariah-compliant?

Yes, Avalon Pharma (4016) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.

4 What are Avalon Pharma dividend distributions?

Avalon Pharma has a dividend yield of 2.36%, with an estimated annual dividend of 1.55 SAR per share.

5 What is Avalon Pharma weekly performance?

Avalon Pharma performance over different time periods: weekly change +8.30%, monthly +8.04%, and year-to-date +6.75%. The stock is currently trading with a volume of 235,658 shares.

6 What is the target level for Avalon Pharma?

According to automated analysis for Avalon Pharma: Short-term target (1-2 weeks): 69.22 SAR. Medium-term target (1-3 months): 72.58 SAR. Support level: 55.60 SAR. Resistance level: 68.40 SAR. Note: These are automated analytical levels and do not constitute investment advice.

Disclaimer

The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.

Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.